Nabriva Therapeutics plc's next confirmed earnings release is scheduled for November 16, 2026.
| Earnings Date | 11/16/2026 |
As of the close on November 16, 2026, Nabriva Therapeutics plc's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.08.
| 200-Day Moving Average | 0.08 |
Nabriva Therapeutics plc's most recent stock split took place on September 16, 2022 with a 25:1 split ratio.
| Last Split Date | 9/16/2022 |
| Split Ratio | 25:1 |
Already premium?